• 
  Kevin Atsou, Anne Auperin, Joël Guigay, Sébastien Salas, Sébastien Benzekry. Tumor kinetics modeling outperforms best overall response for prediction of survival in head and neck squamous cell carcinoma. 2024. ⟨hal-04558029⟩
• 
  Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud, Marie Attard, Claire Bournaud, et al.. MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131 I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated thyroid Cancer. Clinical Cancer Research, 2023, 29 (13), pp.2401-2409. ⟨10.1158/1078-0432.CCR-23-0046⟩. ⟨inserm-04552345⟩
• 
  Grégoire Marret, Stéphane Temam, Maud Kamal, Caroline Even, Jean-Pierre Delord, et al.. Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity. Scientific Reports, 2023, 13, pp.22524. ⟨10.1038/s41598-023-49887-4⟩. ⟨hal-04543900⟩
• 
  Justine Gantzer, Maud Toulmonde, François Séverac, Ali N. Chamseddine, Celine Charon-Barra, et al.. PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent. Cancer, 2024, ⟨10.1002/cncr.35277⟩. ⟨hal-04533834⟩
• 
  Florent Milliet, Alexandre Bozec, Renaud Schiappa, Julien Viotti, Anouchka Modesto, et al.. Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric study. Oral Oncology, 2021, 112, pp.105041. ⟨10.1016/j.oraloncology.2020.105041⟩. ⟨hal-03617423⟩
• 
  Sophie Leboulleux, Daniele Benisvy, David Taieb, Marie Attard, Claire Bournaud, et al.. MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated Thyroid Cancer. Thyroid, 2023, 33 (9), pp.1124-1129. ⟨10.1089/thy.2023.0240⟩. ⟨inserm-04527070⟩
• 
  Sebastien Salas, Guillaume Economos, Damien Hugues, Elise Gilbert, Dominique Gracia, et al.. Legalisation of euthanasia and assisted suicide: advanced cancer patient opinions – cross-sectional multicentre study. BMJ Palliative and supportive care, 2023, 13 (e3), pp.e1335-e1341. ⟨10.1136/spcare-2022-004134⟩. ⟨hal-04382168⟩
• 
  Xavier Pivot, Gilles Romieu, Pierre Fumoleau, Maria Rios, Hervé Bonnefoi, et al.. Constitutional variants are not associated with HER2-positive breast cancer: results from the SIGNAL/PHARE clinical cohort. npj Breast Cancer, 2017, 3 (1), pp.4. ⟨10.1038/s41523-017-0005-y⟩. ⟨cea-04501580⟩
• 
  Juliette Mainguené, Sophie Vacher, Maud Kamal, Abderaouf Hamza, Julien Masliah‐planchon, et al.. Human papilloma virus integration sites and genomic signatures in head and neck squamous cell carcinoma. Molecular Oncology, 2022, 16, pp.3001 - 3016. ⟨10.1002/1878-0261.13219⟩. ⟨hal-04459250⟩
• 
  Imène Mansouri, Rodrigue S Allodji, Catherine Hill, Chiraz El‐fayech, François Pein, et al.. The role of irradiated heart and left ventricular volumes in heart failure occurrence after childhood cancer. European Journal of Heart Failure, 2018, 21 (4), pp.509 - 518. ⟨10.1002/ejhf.1376⟩. ⟨inserm-04439245⟩
• 
  Thibaud Charrier, Nadia Haddy, Boris Schwartz, Neige Journy, Brice Fresneau, et al.. Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors. JACC: CardioOncology, 2023, 5 (6), pp.792-803. ⟨10.1016/j.jaccao.2023.07.008⟩. ⟨inserm-04424032⟩
• 
  Zoé Guillaume, Emeline Colomba, Jonathan Thouvenin, Carolina Saldana, Luca Campedel, et al.. Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study. Cancers, 2022, 14 (7), pp.1678. ⟨10.3390/cancers14071678⟩. ⟨hal-04327308⟩
• 
  Jennifer Le Guevelou, Colin Debaigt, Esma Saada-Bouzid, Julien Viotti, Nazim Khalladi, et al.. Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol.. BMJ Open, 2020, BMJ Open, 10, pp.e038391. ⟨10.1136/bmjopen-2020-038391⟩. ⟨hal-04346738⟩
• 
  Vincent Lavoué, Amélia Favier, Sophie Frank, Gérard Boutet, Anne-Sophie Azuar, et al.. Recommandations pour la pratique clinique du CNGOF. Place de l’auto-examen des seins dans les stratégies de dépistage. Gynécologie Obstétrique Fertilité & Sénologie, 2023, 51 (10), pp.437-447. ⟨10.1016/j.gofs.2023.08.003⟩. ⟨hal-04244323⟩
• 
  Khalil Saleh, Matthieu Carton, Véronique Dieras, Pierre-Etienne Heudel, Etienne Brain, et al.. Impact of body mass index on overall survival in patients with metastatic breast cancer. The Breast, 2021, 55, pp.16-24. ⟨10.1016/j.breast.2020.11.014⟩. ⟨hal-03345238⟩
• 
  F. Gauna, S. Carof, E Mouret‐fourme, I. Coupier, V. Mari, et al.. Links between gender norms and the intergenerational transmission of health information in parents carrying BRCA1/2 pathogenic variants. Journal of Genetic Counseling, 2023, Online ahead of print. ⟨10.1002/jgc4.1734⟩. ⟨inserm-04302095⟩
• 
  Thomas Grinda, Alison Antoine, William Jacot, Paul-Henri Cottu, Thibault de la Motte Rouge, et al.. Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort. European Journal of Cancer, 2023, 189, pp.112935. ⟨10.1016/j.ejca.2023.05.023⟩. ⟨hal-04205902⟩
• 
  Lionel Falchero, Florian Guisier, Marie Darrason, Arnaud Boyer, Charles Dayen, et al.. Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world study. Lung Cancer, 2023, 185, ⟨10.1016/j.lungcan.2023.107379⟩. ⟨hal-04229547⟩
• 
  Brice Paquette, Dewi Vernerey, Bruno Chauffert, Sandrine Dabakuyo, Loic Feuvret, et al.. Prognostic value of health‐related quality of life for death risk stratification in patients with unresectable glioblastoma. Cancer Medicine, 2016, 5 (8), pp.1753-1764. ⟨10.1002/cam4.734⟩. ⟨hal-03036055⟩
• 
  Thibault Escobar, Fanny Orlhac, Anne-Capucine Rollet, Olivier Humbert, Sebastien Vauclin, et al.. Radiomic decision maps reveal patterns discriminating between glioma progression and radiation-induced necrosis in static and dual time [18F]-FDOPA PET. Society of Nuclear Medicine and Molecular Imaging meeting, Jun 2022, Vancouver, Canada. ⟨hal-04248818⟩

127

188